Quoin Pharmaceuticals Ltd (NASDAQ:QNRX)
| 4.77 Delayed Data As of Aug 12 |  -0.05 / -1.04%Today’s Change | 3.58 Today|||52-Week Range 444.00 | -79.03% Year-to-Date |
Latest QNRX News | Press Releases
No recent news for Quoin Pharmaceuticals Ltd.
Today’s Trading
| Previous close | 4.82 |
| Today’s open | 4.88 |
| Day’s range | 4.77 - 4.95 |
| Volume | 2,569 |
| Average volume (3 months) | 1,048,541 |
| Market cap | $3.8M |
Data as of 3:06pm ET, 08/12/2022
Growth & Valuation
| Earnings growth (last year) | +81.12% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.77 |
Competitors
| ---- | ||
| ---- | ||
| ---- | ||
| --Lattice Biologics Lt... | 0.00 | 0.00% |
Data as of 02/14/2022
Financials
| Next reporting date | August 18, 2022 |
| EPS forecast (this quarter) | -$16.46 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$21.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kefar Sava, Tel Aviv |
Forecasts
Chart unavailable
